657 related articles for article (PubMed ID: 26370129)
1. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
[TBL] [Abstract][Full Text] [Related]
2. Production in yeast of pseudotype virus-like particles harboring functionally active antibody fragments neutralizing the cytolytic activity of vaginolysin.
Pleckaityte M; Zvirbliene A; Sezaite I; Gedvilaite A
Microb Cell Fact; 2011 Dec; 10():109. PubMed ID: 22171920
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Trichodysplasia Spinulosa-Associated Polyomavirus Capsid Protein as a New Carrier for Construction of Chimeric Virus-Like Particles Harboring Foreign Epitopes.
Gedvilaite A; Kucinskaite-Kodze I; Lasickiene R; Timinskas A; Vaitiekaite A; Ziogiene D; Zvirbliene A
Viruses; 2015 Jul; 7(8):4204-29. PubMed ID: 26230706
[TBL] [Abstract][Full Text] [Related]
4. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
Kucinskaite-Kodze I; Pleckaityte M; Bremer CM; Seiz PL; Zilnyte M; Bulavaite A; Mickiene G; Zvirblis G; Sasnauskas K; Glebe D; Zvirbliene A
Virus Res; 2016 Jan; 211():209-21. PubMed ID: 26541316
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
[TBL] [Abstract][Full Text] [Related]
6. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
[TBL] [Abstract][Full Text] [Related]
8. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
[TBL] [Abstract][Full Text] [Related]
9. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
[TBL] [Abstract][Full Text] [Related]
10. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity.
Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ
J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047
[TBL] [Abstract][Full Text] [Related]
11. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
12. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
[TBL] [Abstract][Full Text] [Related]
13. The use of recombinant pseudotype virus-like particles harbouring inserted target antigen to generate antibodies against cellular marker p16INK4A.
Lasickienė R; Gedvilaite A; Norkiene M; Simanaviciene V; Sezaite I; Dekaminaviciute D; Shikova E; Zvirbliene A
ScientificWorldJournal; 2012; 2012():263737. PubMed ID: 22629125
[TBL] [Abstract][Full Text] [Related]
14. Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.
Yong CY; Yeap SK; Goh ZH; Ho KL; Omar AR; Tan WS
Appl Environ Microbiol; 2015 Feb; 81(3):882-9. PubMed ID: 25416760
[TBL] [Abstract][Full Text] [Related]
15. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
Arora U; Tyagi P; Swaminathan S; Khanna N
Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
17. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
19. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV/HEV virus-like particles.
Li HZ; Gang HY; Sun QM; Liu X; Ma YB; Sun MS; Dai CB
Chin Med Sci J; 2004 Jun; 19(2):78-83. PubMed ID: 15250239
[TBL] [Abstract][Full Text] [Related]
20. Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg).
Golsaz-Shirazi F; Amiri MM; Farid S; Bahadori M; Bohne F; Altstetter S; Wolff L; Kazemi T; Khoshnoodi J; Hojjat-Farsangi M; Chudy M; Jeddi-Tehrani M; Protzer U; Shokri F
Antiviral Res; 2017 Aug; 144():153-163. PubMed ID: 28641998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
